nodes	percent_of_prediction	percent_of_DWPC	metapath
Trilostane—HSD3B1—Androgen biosynthesis—HSD17B12—peripheral nervous system neoplasm	0.258	0.258	CbGpPWpGaD
Trilostane—HSD3B2—Androgen biosynthesis—HSD17B12—peripheral nervous system neoplasm	0.196	0.196	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of steroid hormones and vitamin D—HSD17B12—peripheral nervous system neoplasm	0.107	0.107	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of steroid hormones and vitamin D—HSD17B12—peripheral nervous system neoplasm	0.0813	0.0813	CbGpPWpGaD
Trilostane—ESR2—Validated nuclear estrogen receptor beta network—SMARCB1—peripheral nervous system neoplasm	0.048	0.048	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.014	0.014	CbGpPWpGaD
Trilostane—HSD3B1—Corticotropin-releasing hormone—GNAS—peripheral nervous system neoplasm	0.0134	0.0134	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.011	0.011	CbGpPWpGaD
Trilostane—HSD3B2—Corticotropin-releasing hormone—GNAS—peripheral nervous system neoplasm	0.0102	0.0102	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.00833	0.00833	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	0.00748	0.00748	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—NTS—peripheral nervous system neoplasm	0.00736	0.00736	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00725	0.00725	CbGpPWpGaD
Trilostane—ESR1—Estrogen signaling pathway—GNAS—peripheral nervous system neoplasm	0.00705	0.00705	CbGpPWpGaD
Trilostane—HSD3B1—Corticotropin-releasing hormone—CASP3—peripheral nervous system neoplasm	0.00669	0.00669	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.00627	0.00627	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—NF1—peripheral nervous system neoplasm	0.00613	0.00613	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00549	0.00549	CbGpPWpGaD
Trilostane—ESR1—FOXM1 transcription factor network—CHEK2—peripheral nervous system neoplasm	0.0052	0.0052	CbGpPWpGaD
Trilostane—HSD3B2—Corticotropin-releasing hormone—CASP3—peripheral nervous system neoplasm	0.00507	0.00507	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.0049	0.0049	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—BARD1—peripheral nervous system neoplasm	0.00468	0.00468	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.00407	0.00407	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—TH—peripheral nervous system neoplasm	0.00406	0.00406	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.00404	0.00404	CbGpPWpGaD
Trilostane—ESR1—FOXM1 transcription factor network—BIRC5—peripheral nervous system neoplasm	0.00377	0.00377	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00371	0.00371	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.0037	0.0037	CbGpPWpGaD
Trilostane—ESR2—Plasma membrane estrogen receptor signaling—NRAS—peripheral nervous system neoplasm	0.00368	0.00368	CbGpPWpGaD
Trilostane—HSD3B1—Corticotropin-releasing hormone—AKT1—peripheral nervous system neoplasm	0.00362	0.00362	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—TH—peripheral nervous system neoplasm	0.00354	0.00354	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—GNS—peripheral nervous system neoplasm	0.00354	0.00354	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—NME1—peripheral nervous system neoplasm	0.00339	0.00339	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—COX2—peripheral nervous system neoplasm	0.00327	0.00327	CbGpPWpGaD
Trilostane—ESR1—Nuclear signaling by ERBB4—PTPN11—peripheral nervous system neoplasm	0.00321	0.00321	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—IFNB1—peripheral nervous system neoplasm	0.00318	0.00318	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.00316	0.00316	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.00308	0.00308	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.00307	0.00307	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.00302	0.00302	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—NF1—peripheral nervous system neoplasm	0.00289	0.00289	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.0028	0.0028	CbGpPWpGaD
Trilostane—HSD3B2—Corticotropin-releasing hormone—AKT1—peripheral nervous system neoplasm	0.00274	0.00274	CbGpPWpGaD
Trilostane—ESR2—Plasma membrane estrogen receptor signaling—HRAS—peripheral nervous system neoplasm	0.00269	0.00269	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—GNS—peripheral nervous system neoplasm	0.00268	0.00268	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—NME1—peripheral nervous system neoplasm	0.00257	0.00257	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.00256	0.00256	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.00252	0.00252	CbGpPWpGaD
Trilostane—ESR1—FOXM1 transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.0025	0.0025	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—COX2—peripheral nervous system neoplasm	0.00248	0.00248	CbGpPWpGaD
Trilostane—ESR2—Validated nuclear estrogen receptor alpha network—MYC—peripheral nervous system neoplasm	0.0024	0.0024	CbGpPWpGaD
Trilostane—ESR2—Plasma membrane estrogen receptor signaling—AKT1—peripheral nervous system neoplasm	0.00238	0.00238	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—EED—peripheral nervous system neoplasm	0.00216	0.00216	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—ENO2—peripheral nervous system neoplasm	0.00214	0.00214	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—AURKA—peripheral nervous system neoplasm	0.00209	0.00209	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—PTPN11—peripheral nervous system neoplasm	0.0019	0.0019	CbGpPWpGaD
Trilostane—ESR1—Estrogen signaling pathway—AKT1—peripheral nervous system neoplasm	0.0019	0.0019	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.00187	0.00187	CbGpPWpGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—NRAS—peripheral nervous system neoplasm	0.00185	0.00185	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—BCHE—peripheral nervous system neoplasm	0.00181	0.00181	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—SUZ12—peripheral nervous system neoplasm	0.00173	0.00173	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.00173	0.00173	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—TH—peripheral nervous system neoplasm	0.0017	0.0017	CbGpPWpGaD
Trilostane—ESR1—FOXM1 transcription factor network—MYC—peripheral nervous system neoplasm	0.00169	0.00169	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	0.00169	0.00169	CbGpPWpGaD
Trilostane—ESR1—LKB1 signaling events—MYC—peripheral nervous system neoplasm	0.00166	0.00166	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.00166	0.00166	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—ENO2—peripheral nervous system neoplasm	0.00163	0.00163	CbGpPWpGaD
Trilostane—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—peripheral nervous system neoplasm	0.00161	0.00161	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	0.00158	0.00158	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.00155	0.00155	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.00151	0.00151	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—ERBB2—peripheral nervous system neoplasm	0.0015	0.0015	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.00141	0.00141	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	0.00141	0.00141	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—GNAS—peripheral nervous system neoplasm	0.00139	0.00139	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—BCHE—peripheral nervous system neoplasm	0.00137	0.00137	CbGpPWpGaD
Trilostane—ESR1—LKB1 signaling events—TP53—peripheral nervous system neoplasm	0.00137	0.00137	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—ABCB1—peripheral nervous system neoplasm	0.00136	0.00136	CbGpPWpGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—HRAS—peripheral nervous system neoplasm	0.00136	0.00136	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.00131	0.00131	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.00129	0.00129	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—TH—peripheral nervous system neoplasm	0.00129	0.00129	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.00128	0.00128	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.00127	0.00127	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	0.00124	0.00124	CbGpPWpGaD
Trilostane—ESR1—Validated nuclear estrogen receptor alpha network—MYC—peripheral nervous system neoplasm	0.00121	0.00121	CbGpPWpGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—AKT1—peripheral nervous system neoplasm	0.0012	0.0012	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—MYC—peripheral nervous system neoplasm	0.00115	0.00115	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—MYC—peripheral nervous system neoplasm	0.00113	0.00113	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—EED—peripheral nervous system neoplasm	0.00109	0.00109	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—PTPN11—peripheral nervous system neoplasm	0.00108	0.00108	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—GNAS—peripheral nervous system neoplasm	0.00105	0.00105	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—ABCB1—peripheral nervous system neoplasm	0.00103	0.00103	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—peripheral nervous system neoplasm	0.001	0.001	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	0.001	0.001	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—TP53—peripheral nervous system neoplasm	0.000925	0.000925	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—SUZ12—peripheral nervous system neoplasm	0.000872	0.000872	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—ERBB2—peripheral nervous system neoplasm	0.000854	0.000854	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—HRAS—peripheral nervous system neoplasm	0.000837	0.000837	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000821	0.000821	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—AKT1—peripheral nervous system neoplasm	0.000799	0.000799	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.00078	0.00078	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—AKT1—peripheral nervous system neoplasm	0.000739	0.000739	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	0.000712	0.000712	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—peripheral nervous system neoplasm	0.000695	0.000695	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000694	0.000694	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—NRAS—peripheral nervous system neoplasm	0.00065	0.00065	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000646	0.000646	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000609	0.000609	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000513	0.000513	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000504	0.000504	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	0.0005	0.0005	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	0.000497	0.000497	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000492	0.000492	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—HRAS—peripheral nervous system neoplasm	0.000476	0.000476	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000422	0.000422	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—AKT1—peripheral nervous system neoplasm	0.00042	0.00042	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000414	0.000414	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000389	0.000389	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—AKT1—peripheral nervous system neoplasm	0.000375	0.000375	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000359	0.000359	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.00035	0.00035	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—AKT1—peripheral nervous system neoplasm	0.000284	0.000284	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000269	0.000269	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	0.000251	0.000251	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—MYC—peripheral nervous system neoplasm	0.000239	0.000239	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.00023	0.00023	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.00022	0.00022	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000202	0.000202	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—AKT1—peripheral nervous system neoplasm	0.000166	0.000166	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.00014	0.00014	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—MYC—peripheral nervous system neoplasm	0.000121	0.000121	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000111	0.000111	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.0001	0.0001	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.42e-05	8.42e-05	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—AKT1—peripheral nervous system neoplasm	8.37e-05	8.37e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.84e-05	7.84e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.44e-05	6.44e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.16e-05	6.16e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.44e-05	5.44e-05	CbGpPWpGaD
